Need help finding what you are looking for?
Contact Us
PUBLISHER: 360iResearch | PRODUCT CODE: 2143593
PUBLISHER: 360iResearch | PRODUCT CODE: 2143593
Pharmaceutical Outsourcing Services Market - Global Forecast 2026-2032
PUBLISHED:
PAGES: 190 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The Pharmaceutical Outsourcing Services Market is projected to grow by USD 92.48 billion at a CAGR of 6.27% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 60.42 billion |
| Estimated Year [2026] | USD 63.95 billion |
| Forecast Year [2032] | USD 92.48 billion |
| CAGR (%) | 6.27% |
Pharmaceutical Outsourcing Services: Executive Overview
Pharmaceutical outsourcing services encompass external support for drug discovery, development, manufacturing, quality operations, regulatory activities, clinical research, logistics, and related functions. The sector enables pharmaceutical and biotechnology organizations to access specialized capabilities, flexible capacity, and geographically distributed operating models while maintaining oversight of product quality, patient safety, data integrity, and compliance. Demand is shaped by increasingly complex therapies, more demanding evidence requirements, supply-chain resilience priorities, and the need to coordinate development and commercialization across multiple jurisdictions.
How Complexity and Resilience Are Reshaping Outsourcing
The outsourcing landscape is shifting from transactional procurement toward integrated, risk-managed partnerships. Sponsors increasingly evaluate providers on technical depth, quality systems, regulatory readiness, continuity planning, technology interoperability, and their ability to support programs across development stages. Advanced modalities, personalized medicines, sterile manufacturing, biologics, and combination products require specialized facilities, analytical methods, and workforce capabilities. At the same time, geopolitical uncertainty, transport disruption, changing trade policies, and concentration risk are encouraging dual sourcing, regional capacity, stronger supplier qualification, and more transparent subcontractor governance.
Artificial Intelligence Accelerates Delivery While Raising Governance Requirements
Artificial intelligence is being applied across study design, protocol feasibility, patient identification, pharmacovigilance, document generation, manufacturing analytics, laboratory workflows, quality investigations, and supply-chain planning. Its practical value depends on validated data, controlled interfaces, human review, model monitoring, cybersecurity, and clear accountability for decisions. Outsourcing providers that combine AI with robust validation and regulatory documentation can improve consistency and responsiveness, but poorly governed deployment may introduce bias, explainability gaps, data-protection concerns, and inspection risk. Leaders should therefore treat AI as a governed operational capability rather than an independent replacement for scientific and quality expertise.
Regional Dynamics: Local Compliance and Distributed Capability Matter
North America remains a major center for pharmaceutical innovation, clinical development, advanced manufacturing, and regulatory activity, with strong emphasis on quality, data integrity, and supply continuity. Europe combines sophisticated research infrastructure with complex country-level operating requirements, making harmonized quality and regulatory coordination important. Asia-Pacific offers broad technical talent, manufacturing depth, and growing development capabilities, while sponsors continue to assess compliance maturity, intellectual-property protection, and resilience across jurisdictions. Latin America provides opportunities in clinical research, manufacturing support, and regional access, subject to varied regulatory and logistics conditions. The Middle East is developing life-sciences infrastructure and localization agendas, while Africa presents emerging clinical, manufacturing, and health-system opportunities alongside infrastructure, skills, and regulatory-capacity considerations.
Group Insights: Cooperation Frameworks Influence Operating Priorities
ASEAN members are relevant to regional clinical research, manufacturing, and supply-chain networks, although regulatory alignment and capability differ across markets. BRICS economies bring substantial scientific, manufacturing, and patient-population resources, while cross-border coordination, intellectual-property considerations, and policy variation require careful management. The European Union supports integrated development and manufacturing strategies through shared frameworks, but national implementation and market-access processes still require local expertise. G7 environments generally emphasize advanced innovation, stringent oversight, and resilient supply networks. GCC states are pursuing healthcare diversification, pharmaceutical localization, and specialized infrastructure. NATO countries collectively underscore the importance of cybersecurity, continuity planning, and protection of critical health-related supply chains.
Country Insights: Capabilities Differ Across Innovation, Manufacturing, and Regulation
Australia offers strong clinical research capabilities and a regulated healthcare environment. Brazil provides a large and diverse healthcare ecosystem, with regulatory and logistical complexity requiring local execution. Canada contributes research, clinical, and manufacturing expertise across a geographically broad system. China combines extensive manufacturing and development capabilities with evolving regulatory, data, and market-access requirements. France, Germany, Italy, and Spain provide established research, manufacturing, and healthcare infrastructure within a coordinated European context, while national procedures remain important. India is a major source of pharmaceutical manufacturing, analytical, clinical, and technical services, with quality consistency and oversight central to partner selection. Japan emphasizes high-quality development and manufacturing under distinct regulatory expectations. Mexico supports regional manufacturing and clinical activity, benefiting from proximity to North American supply chains. Russia presents specialized scientific and manufacturing capabilities but requires careful assessment of sanctions, trade restrictions, compliance, and operational continuity. South Korea is strong in biopharmaceutical development and manufacturing. The United Kingdom remains an important center for life-sciences research, clinical development, regulation, and advanced services. The United States combines deep innovation, clinical, regulatory, and manufacturing ecosystems with demanding expectations for compliance, cybersecurity, and supply assurance.
Leadership Priorities for More Resilient Outsourcing Programs
Industry leaders should segment outsourced activities by criticality, technical complexity, patient impact, and switching difficulty, then apply proportionate qualification and oversight. Contracts should define quality responsibilities, data ownership, audit access, change control, business continuity, subcontracting, cybersecurity, and escalation procedures. Sponsors should develop multisource or regional options for vulnerable inputs, maintain realistic technology-transfer plans, and monitor capacity, lead times, deviations, and regulatory signals through shared performance dashboards. AI adoption should begin with high-value, controllable use cases supported by validation, human review, and documented governance. Finally, organizations should align provider selection with modality expertise, inspection history, workforce depth, geographic fit, and the ability to communicate transparently when conditions change.
Methodology: Structured Synthesis of Pharmaceutical Outsourcing Drivers
This executive summary uses a structured, qualitative assessment of the pharmaceutical outsourcing services landscape. The analysis organizes established industry themes across service activities, operating risks, technology adoption, regulatory expectations, supply-chain considerations, and geographic capabilities. Regional, group, and country perspectives are integrated to reflect differences in infrastructure, talent, compliance environments, healthcare systems, and localization priorities. Claims are framed as directional industry insights rather than quantified market measurements; no estimates, market sizes, shares, or forecasts are used. Interpretation should be supplemented with current regulatory materials, supplier audits, transaction-specific due diligence, and program-level technical assessments before decisions are made.
Conclusion: Strategic Outsourcing Requires Capability, Control, and Resilience
Pharmaceutical outsourcing is becoming a core operating model for accessing specialized expertise and flexible capacity, not merely a way to reduce internal workload. Success depends on matching each activity with the right technical and geographic capability while preserving sponsor control over quality, data, compliance, and continuity. Artificial intelligence can strengthen performance when governed responsibly, and regional diversification can reduce concentration risk when supported by rigorous qualification. Leaders that build transparent partnerships, resilient networks, and evidence-based oversight will be better positioned to manage scientific complexity and evolving regulatory expectations.
Product Code: MRR-9C4233EE7D78
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Definition
- 1.3. Market Segmentation & Coverage
- 1.4. Years Considered for the Study
- 1.5. Currency Considered for the Study
- 1.6. Language Considered for the Study
- 1.7. Key Stakeholders
2. Research Methodology
- 2.1. Introduction
- 2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
- 2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
- 2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
- 2.5. Data Triangulation
- 2.6. Research Outcomes
- 2.7. Research Assumptions
- 2.8. Research Limitations
3. Executive Summary
- 3.1. Introduction
- 3.2. CXO Perspective
- 3.3. New Revenue Opportunities
- 3.4. Next-Generation Business Models
- 3.5. Industry Roadmap
4. Market Overview
- 4.1. Introduction
- 4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
- 4.3. Market Dynamics
- 4.3.1. Key Drivers
- 4.3.2. Key Restraints
- 4.3.3. Key Opportunities
- 4.3.4. Key Challenges
- 4.4. Porter's Five Forces Analysis
- 4.5. PESTLE Analysis
- 4.6. Market Outlook
- 4.6.1. Near-Term Market Outlook (0-2 Years)
- 4.6.2. Medium-Term Market Outlook (3-5 Years)
- 4.6.3. Long-Term Market Outlook (5-10 Years)
- 4.7. Go-to-Market Strategy
5. Market Insights
- 5.1. Consumer Insights & End-User Perspective
- 5.2. Consumer Experience Benchmarking
- 5.3. Opportunity Mapping
- 5.4. Distribution Channel Analysis
- 5.5. Pricing Trend Analysis
- 5.6. Regulatory Compliance & Standards Framework
- 5.7. ESG & Sustainability Analysis
- 5.8. Disruption & Risk Scenarios
- 5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Pharmaceutical Outsourcing Services Market, by Service Type
- 7.1. Introduction
- 7.2. Analytical Testing
- 7.2.1. Bioanalytical Testing
- 7.2.2. Microbiological Testing
- 7.2.3. Physicochemical Testing
- 7.2.4. Stability Testing
- 7.3. Clinical Trial Management
- 7.3.1. Phase I Management
- 7.3.2. Phase Ii Management
- 7.3.3. Phase Iii Management
- 7.3.4. Phase Iv Monitoring
- 7.4. Manufacturing Services
- 7.4.1. Api Manufacturing
- 7.4.2. Biologics Manufacturing
- 7.4.3. Finished Dosage Manufacturing
- 7.5. R&D Services
- 7.5.1. Discovery Research
- 7.5.2. Formulation Development
- 7.5.3. Preclinical Testing
- 7.5.4. Process Development
- 7.6. Regulatory Consulting
- 7.6.1. Compliance & Quality Assurance
- 7.6.2. Drug Safety & Pharmacovigilance
- 7.6.3. Market Access Consulting
- 7.6.4. Regulatory Submissions
8. Pharmaceutical Outsourcing Services Market, by Development Phase
- 8.1. Introduction
- 8.2. Phase I
- 8.3. Phase II
- 8.4. Phase III
- 8.5. Phase IV
- 8.6. Preclinical
9. Pharmaceutical Outsourcing Services Market, by Therapeutic Area
- 9.1. Introduction
- 9.2. Cardiology
- 9.3. Infectious Diseases
- 9.4. Neurology
- 9.5. Oncology
10. Pharmaceutical Outsourcing Services Market, by End User
- 10.1. Introduction
- 10.2. Academic & Research Institutes
- 10.3. Big Pharma
- 10.4. Biotech
- 10.5. Generic Drug Manufacturers
11. Pharmaceutical Outsourcing Services Market, by Contract Model
- 11.1. Introduction
- 11.2. Dedicated Project Team
- 11.2.1. Onsite Teams
- 11.2.2. Remote Teams
- 11.3. Fixed Price
- 11.3.1. Bundled Services
- 11.3.2. Per-Study Pricing
- 11.4. Risk-Sharing
- 11.4.1. Milestone-Based
- 11.4.2. Revenue Sharing
- 11.5. Time & Material
- 11.5.1. Daily Rate Engagement
- 11.5.2. Hourly Engagement
12. Pharmaceutical Outsourcing Services Market, by Region
- 12.1. Introduction
- 12.2. Asia-Pacific
- 12.3. North America
- 12.4. Latin America
- 12.5. Europe
- 12.6. Middle East
- 12.7. Africa
13. Pharmaceutical Outsourcing Services Market, by Group
- 13.1. Introduction
- 13.2. ASEAN
- 13.3. GCC
- 13.4. European Union
- 13.5. BRICS
- 13.6. G7
- 13.7. NATO
14. Pharmaceutical Outsourcing Services Market, by Country
- 14.1. Introduction
- 14.2. United States
- 14.3. Canada
- 14.4. Mexico
- 14.5. Brazil
- 14.6. United Kingdom
- 14.7. Germany
- 14.8. France
- 14.9. Russia
- 14.10. Italy
- 14.11. Spain
- 14.12. China
- 14.13. India
- 14.14. Japan
- 14.15. Australia
- 14.16. South Korea
15. Competitive Landscape
- 15.1. Market Share Analysis, 2025
- 15.2. Market Concentration Analysis, 2025
- 15.2.1. Concentration Ratio (CR)
- 15.2.2. Herfindahl Hirschman Index (HHI)
- 15.3. Recent Developments & Impact Analysis, 2025
- 15.4. Product Portfolio Analysis, 2025
- 15.5. Benchmarking Analysis, 2025
16. Company Profiles
- 16.1. Aenova Holding GmbH
- 16.2. AGC Biologics Inc
- 16.3. Alcami Corporation
- 16.4. Asymchem Laboratories (Tianjin) Co Ltd
- 16.5. Boehringer Ingelheim GmbH
- 16.6. Cambrex Corporation
- 16.7. Catalent, Inc.
- 16.8. Divi's Laboratories Limited
- 16.9. Eurofins Scientific SE
- 16.10. Evonik Industries AG
- 16.11. FAMAR Health Care Services AG
- 16.12. Hovione LLC
- 16.13. Lonza Group AG
- 16.14. Metrics Contract Services LLC
- 16.15. Neuland Laboratories Limited
- 16.16. Piramal Pharma Ltd
- 16.17. Porton Pharma Solutions Limited
- 16.18. Recipharm AB
- 16.19. Samsung Biologics Co., Ltd.
- 16.20. Siegfried Holding AG
- 16.21. Syngene International Limited
- 16.22. Thermo Fisher Scientific Inc.
- 16.23. WuXi AppTec Co., Ltd
17. Key Experts
Product Code: MRR-9C4233EE7D78
LIST OF FIGURES
- FIGURE 1. Global Pharmaceutical Outsourcing Services Market, Years Considered for the Study
- FIGURE 2. Global Pharmaceutical Outsourcing Services Market, Research Design
- FIGURE 3. Global Pharmaceutical Outsourcing Services Market, Research Framework
- FIGURE 4. Global Pharmaceutical Outsourcing Services Market, Data Triangulation
- FIGURE 5. Global Pharmaceutical Outsourcing Services Market Size, 2017-2032 (USD Million)
- FIGURE 6. Global Pharmaceutical Outsourcing Services Market Size, by Service Type, 2025 vs 2032 (%)
- FIGURE 7. Global Pharmaceutical Outsourcing Services Market Size, by Service Type, 2025 vs 2026 vs 2032 (USD Million)
- FIGURE 8. Global Pharmaceutical Outsourcing Services Market Size, by Development Phase, 2025 vs 2032 (%)
- FIGURE 9. Global Pharmaceutical Outsourcing Services Market Size, by Development Phase, 2025 vs 2026 vs 2032 (USD Million)
- FIGURE 10. Global Pharmaceutical Outsourcing Services Market Size, by Therapeutic Area, 2025 vs 2032 (%)
- FIGURE 11. Global Pharmaceutical Outsourcing Services Market Size, by Therapeutic Area, 2025 vs 2026 vs 2032 (USD Million)
- FIGURE 12. Global Pharmaceutical Outsourcing Services Market Size, by End User, 2025 vs 2032 (%)
- FIGURE 13. Global Pharmaceutical Outsourcing Services Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
- FIGURE 14. Global Pharmaceutical Outsourcing Services Market Size, by Contract Model, 2025 vs 2032 (%)
- FIGURE 15. Global Pharmaceutical Outsourcing Services Market Size, by Contract Model, 2025 vs 2026 vs 2032 (USD Million)
- FIGURE 16. Global Pharmaceutical Outsourcing Services Market Size, by Region, 2025 vs 2032 (%)
- FIGURE 17. Global Pharmaceutical Outsourcing Services Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
- FIGURE 18. Global Pharmaceutical Outsourcing Services Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
- FIGURE 19. Global Pharmaceutical Outsourcing Services Market Size, by Country, 2025 vs 2032 (%)
- FIGURE 20. Global Pharmaceutical Outsourcing Services Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
- FIGURE 21. Global Pharmaceutical Outsourcing Services Market Share, by Key Player, 2025
LIST OF TABLES
- TABLE 1. Global Pharmaceutical Outsourcing Services Market Segmentation & Coverage
- TABLE 2. Global Pharmaceutical Outsourcing Services Market Size, 2017-2032 (USD Million)
- TABLE 3. Global Pharmaceutical Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
- TABLE 4. Global Analytical Testing Market Size, by Region, 2017-2032 (USD Million)
- TABLE 5. Global Analytical Testing Market Size, by Group, 2017-2032 (USD Million)
- TABLE 6. Global Analytical Testing Market Size, by Country, 2017-2032 (USD Million)
- TABLE 7. Global Bioanalytical Testing Market Size, by Region, 2017-2032 (USD Million)
- TABLE 8. Global Bioanalytical Testing Market Size, by Group, 2017-2032 (USD Million)
- TABLE 9. Global Bioanalytical Testing Market Size, by Country, 2017-2032 (USD Million)
- TABLE 10. Global Microbiological Testing Market Size, by Region, 2017-2032 (USD Million)
- TABLE 11. Global Microbiological Testing Market Size, by Group, 2017-2032 (USD Million)
- TABLE 12. Global Microbiological Testing Market Size, by Country, 2017-2032 (USD Million)
- TABLE 13. Global Physicochemical Testing Market Size, by Region, 2017-2032 (USD Million)
- TABLE 14. Global Physicochemical Testing Market Size, by Group, 2017-2032 (USD Million)
- TABLE 15. Global Physicochemical Testing Market Size, by Country, 2017-2032 (USD Million)
- TABLE 16. Global Stability Testing Market Size, by Region, 2017-2032 (USD Million)
- TABLE 17. Global Stability Testing Market Size, by Group, 2017-2032 (USD Million)
- TABLE 18. Global Stability Testing Market Size, by Country, 2017-2032 (USD Million)
- TABLE 19. Global Clinical Trial Management Market Size, by Region, 2017-2032 (USD Million)
- TABLE 20. Global Clinical Trial Management Market Size, by Group, 2017-2032 (USD Million)
- TABLE 21. Global Clinical Trial Management Market Size, by Country, 2017-2032 (USD Million)
- TABLE 22. Global Phase I Management Market Size, by Region, 2017-2032 (USD Million)
- TABLE 23. Global Phase I Management Market Size, by Group, 2017-2032 (USD Million)
- TABLE 24. Global Phase I Management Market Size, by Country, 2017-2032 (USD Million)
- TABLE 25. Global Phase Ii Management Market Size, by Region, 2017-2032 (USD Million)
- TABLE 26. Global Phase Ii Management Market Size, by Group, 2017-2032 (USD Million)
- TABLE 27. Global Phase Ii Management Market Size, by Country, 2017-2032 (USD Million)
- TABLE 28. Global Phase Iii Management Market Size, by Region, 2017-2032 (USD Million)
- TABLE 29. Global Phase Iii Management Market Size, by Group, 2017-2032 (USD Million)
- TABLE 30. Global Phase Iii Management Market Size, by Country, 2017-2032 (USD Million)
- TABLE 31. Global Phase Iv Monitoring Market Size, by Region, 2017-2032 (USD Million)
- TABLE 32. Global Phase Iv Monitoring Market Size, by Group, 2017-2032 (USD Million)
- TABLE 33. Global Phase Iv Monitoring Market Size, by Country, 2017-2032 (USD Million)
- TABLE 34. Global Manufacturing Services Market Size, by Region, 2017-2032 (USD Million)
- TABLE 35. Global Manufacturing Services Market Size, by Group, 2017-2032 (USD Million)
- TABLE 36. Global Manufacturing Services Market Size, by Country, 2017-2032 (USD Million)
- TABLE 37. Global Api Manufacturing Market Size, by Region, 2017-2032 (USD Million)
- TABLE 38. Global Api Manufacturing Market Size, by Group, 2017-2032 (USD Million)
- TABLE 39. Global Api Manufacturing Market Size, by Country, 2017-2032 (USD Million)
- TABLE 40. Global Biologics Manufacturing Market Size, by Region, 2017-2032 (USD Million)
- TABLE 41. Global Biologics Manufacturing Market Size, by Group, 2017-2032 (USD Million)
- TABLE 42. Global Biologics Manufacturing Market Size, by Country, 2017-2032 (USD Million)
- TABLE 43. Global Finished Dosage Manufacturing Market Size, by Region, 2017-2032 (USD Million)
- TABLE 44. Global Finished Dosage Manufacturing Market Size, by Group, 2017-2032 (USD Million)
- TABLE 45. Global Finished Dosage Manufacturing Market Size, by Country, 2017-2032 (USD Million)
- TABLE 46. Global R&D Services Market Size, by Region, 2017-2032 (USD Million)
- TABLE 47. Global R&D Services Market Size, by Group, 2017-2032 (USD Million)
- TABLE 48. Global R&D Services Market Size, by Country, 2017-2032 (USD Million)
- TABLE 49. Global Discovery Research Market Size, by Region, 2017-2032 (USD Million)
- TABLE 50. Global Discovery Research Market Size, by Group, 2017-2032 (USD Million)
- TABLE 51. Global Discovery Research Market Size, by Country, 2017-2032 (USD Million)
- TABLE 52. Global Formulation Development Market Size, by Region, 2017-2032 (USD Million)
- TABLE 53. Global Formulation Development Market Size, by Group, 2017-2032 (USD Million)
- TABLE 54. Global Formulation Development Market Size, by Country, 2017-2032 (USD Million)
- TABLE 55. Global Preclinical Testing Market Size, by Region, 2017-2032 (USD Million)
- TABLE 56. Global Preclinical Testing Market Size, by Group, 2017-2032 (USD Million)
- TABLE 57. Global Preclinical Testing Market Size, by Country, 2017-2032 (USD Million)
- TABLE 58. Global Process Development Market Size, by Region, 2017-2032 (USD Million)
- TABLE 59. Global Process Development Market Size, by Group, 2017-2032 (USD Million)
- TABLE 60. Global Process Development Market Size, by Country, 2017-2032 (USD Million)
- TABLE 61. Global Regulatory Consulting Market Size, by Region, 2017-2032 (USD Million)
- TABLE 62. Global Regulatory Consulting Market Size, by Group, 2017-2032 (USD Million)
- TABLE 63. Global Regulatory Consulting Market Size, by Country, 2017-2032 (USD Million)
- TABLE 64. Global Compliance & Quality Assurance Market Size, by Region, 2017-2032 (USD Million)
- TABLE 65. Global Compliance & Quality Assurance Market Size, by Group, 2017-2032 (USD Million)
- TABLE 66. Global Compliance & Quality Assurance Market Size, by Country, 2017-2032 (USD Million)
- TABLE 67. Global Drug Safety & Pharmacovigilance Market Size, by Region, 2017-2032 (USD Million)
- TABLE 68. Global Drug Safety & Pharmacovigilance Market Size, by Group, 2017-2032 (USD Million)
- TABLE 69. Global Drug Safety & Pharmacovigilance Market Size, by Country, 2017-2032 (USD Million)
- TABLE 70. Global Market Access Consulting Market Size, by Region, 2017-2032 (USD Million)
- TABLE 71. Global Market Access Consulting Market Size, by Group, 2017-2032 (USD Million)
- TABLE 72. Global Market Access Consulting Market Size, by Country, 2017-2032 (USD Million)
- TABLE 73. Global Regulatory Submissions Market Size, by Region, 2017-2032 (USD Million)
- TABLE 74. Global Regulatory Submissions Market Size, by Group, 2017-2032 (USD Million)
- TABLE 75. Global Regulatory Submissions Market Size, by Country, 2017-2032 (USD Million)
- TABLE 76. Global Pharmaceutical Outsourcing Services Market Size, by Development Phase, 2017-2032 (USD Million)
- TABLE 77. Global Phase I Market Size, by Region, 2017-2032 (USD Million)
- TABLE 78. Global Phase I Market Size, by Group, 2017-2032 (USD Million)
- TABLE 79. Global Phase I Market Size, by Country, 2017-2032 (USD Million)
- TABLE 80. Global Phase II Market Size, by Region, 2017-2032 (USD Million)
- TABLE 81. Global Phase II Market Size, by Group, 2017-2032 (USD Million)
- TABLE 82. Global Phase II Market Size, by Country, 2017-2032 (USD Million)
- TABLE 83. Global Phase III Market Size, by Region, 2017-2032 (USD Million)
- TABLE 84. Global Phase III Market Size, by Group, 2017-2032 (USD Million)
- TABLE 85. Global Phase III Market Size, by Country, 2017-2032 (USD Million)
- TABLE 86. Global Phase IV Market Size, by Region, 2017-2032 (USD Million)
- TABLE 87. Global Phase IV Market Size, by Group, 2017-2032 (USD Million)
- TABLE 88. Global Phase IV Market Size, by Country, 2017-2032 (USD Million)
- TABLE 89. Global Preclinical Market Size, by Region, 2017-2032 (USD Million)
- TABLE 90. Global Preclinical Market Size, by Group, 2017-2032 (USD Million)
- TABLE 91. Global Preclinical Market Size, by Country, 2017-2032 (USD Million)
- TABLE 92. Global Pharmaceutical Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
- TABLE 93. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
- TABLE 94. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
- TABLE 95. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
- TABLE 96. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
- TABLE 97. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
- TABLE 98. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
- TABLE 99. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
- TABLE 100. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
- TABLE 101. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
- TABLE 102. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
- TABLE 103. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
- TABLE 104. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
- TABLE 105. Global Pharmaceutical Outsourcing Services Market Size, by End User, 2017-2032 (USD Million)
- TABLE 106. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
- TABLE 107. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
- TABLE 108. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
- TABLE 109. Global Big Pharma Market Size, by Region, 2017-2032 (USD Million)
- TABLE 110. Global Big Pharma Market Size, by Group, 2017-2032 (USD Million)
- TABLE 111. Global Big Pharma Market Size, by Country, 2017-2032 (USD Million)
- TABLE 112. Global Biotech Market Size, by Region, 2017-2032 (USD Million)
- TABLE 113. Global Biotech Market Size, by Group, 2017-2032 (USD Million)
- TABLE 114. Global Biotech Market Size, by Country, 2017-2032 (USD Million)
- TABLE 115. Global Generic Drug Manufacturers Market Size, by Region, 2017-2032 (USD Million)
- TABLE 116. Global Generic Drug Manufacturers Market Size, by Group, 2017-2032 (USD Million)
- TABLE 117. Global Generic Drug Manufacturers Market Size, by Country, 2017-2032 (USD Million)
- TABLE 118. Global Pharmaceutical Outsourcing Services Market Size, by Contract Model, 2017-2032 (USD Million)
- TABLE 119. Global Dedicated Project Team Market Size, by Region, 2017-2032 (USD Million)
- TABLE 120. Global Dedicated Project Team Market Size, by Group, 2017-2032 (USD Million)
- TABLE 121. Global Dedicated Project Team Market Size, by Country, 2017-2032 (USD Million)
- TABLE 122. Global Onsite Teams Market Size, by Region, 2017-2032 (USD Million)
- TABLE 123. Global Onsite Teams Market Size, by Group, 2017-2032 (USD Million)
- TABLE 124. Global Onsite Teams Market Size, by Country, 2017-2032 (USD Million)
- TABLE 125. Global Remote Teams Market Size, by Region, 2017-2032 (USD Million)
- TABLE 126. Global Remote Teams Market Size, by Group, 2017-2032 (USD Million)
- TABLE 127. Global Remote Teams Market Size, by Country, 2017-2032 (USD Million)
- TABLE 128. Global Fixed Price Market Size, by Region, 2017-2032 (USD Million)
- TABLE 129. Global Fixed Price Market Size, by Group, 2017-2032 (USD Million)
- TABLE 130. Global Fixed Price Market Size, by Country, 2017-2032 (USD Million)
- TABLE 131. Global Bundled Services Market Size, by Region, 2017-2032 (USD Million)
- TABLE 132. Global Bundled Services Market Size, by Group, 2017-2032 (USD Million)
- TABLE 133. Global Bundled Services Market Size, by Country, 2017-2032 (USD Million)
- TABLE 134. Global Per-Study Pricing Market Size, by Region, 2017-2032 (USD Million)
- TABLE 135. Global Per-Study Pricing Market Size, by Group, 2017-2032 (USD Million)
- TABLE 136. Global Per-Study Pricing Market Size, by Country, 2017-2032 (USD Million)
- TABLE 137. Global Risk-Sharing Market Size, by Region, 2017-2032 (USD Million)
- TABLE 138. Global Risk-Sharing Market Size, by Group, 2017-2032 (USD Million)
- TABLE 139. Global Risk-Sharing Market Size, by Country, 2017-2032 (USD Million)
- TABLE 140. Global Milestone-Based Market Size, by Region, 2017-2032 (USD Million)
- TABLE 141. Global Milestone-Based Market Size, by Group, 2017-2032 (USD Million)
- TABLE 142. Global Milestone-Based Market Size, by Country, 2017-2032 (USD Million)
- TABLE 143. Global Revenue Sharing Market Size, by Region, 2017-2032 (USD Million)
- TABLE 144. Global Revenue Sharing Market Size, by Group, 2017-2032 (USD Million)
- TABLE 145. Global Revenue Sharing Market Size, by Country, 2017-2032 (USD Million)
- TABLE 146. Global Time & Material Market Size, by Region, 2017-2032 (USD Million)
- TABLE 147. Global Time & Material Market Size, by Group, 2017-2032 (USD Million)
- TABLE 148. Global Time & Material Market Size, by Country, 2017-2032 (USD Million)
- TABLE 149. Global Daily Rate Engagement Market Size, by Region, 2017-2032 (USD Million)
- TABLE 150. Global Daily Rate Engagement Market Size, by Group, 2017-2032 (USD Million)
- TABLE 151. Global Daily Rate Engagement Market Size, by Country, 2017-2032 (USD Million)
- TABLE 152. Global Hourly Engagement Market Size, by Region, 2017-2032 (USD Million)
- TABLE 153. Global Hourly Engagement Market Size, by Group, 2017-2032 (USD Million)
- TABLE 154. Global Hourly Engagement Market Size, by Country, 2017-2032 (USD Million)
- TABLE 155. Global Pharmaceutical Outsourcing Services Market Size, by Region, 2017-2032 (USD Million)
- TABLE 156. Asia-Pacific Pharmaceutical Outsourcing Services Market Size, by Region, 2017-2032 (USD Million)
- TABLE 157. Asia-Pacific Pharmaceutical Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
- TABLE 158. Asia-Pacific Pharmaceutical Outsourcing Services Market Size, by Analytical Testing, 2017-2032 (USD Million)
- TABLE 159. Asia-Pacific Pharmaceutical Outsourcing Services Market Size, by Clinical Trial Management, 2017-2032 (USD Million)
- TABLE 160. Asia-Pacific Pharmaceutical Outsourcing Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
- TABLE 161. Asia-Pacific Pharmaceutical Outsourcing Services Market Size, by R&D Services, 2017-2032 (USD Million)
- TABLE 162. Asia-Pacific Pharmaceutical Outsourcing Services Market Size, by Regulatory Consulting, 2017-2032 (USD Million)
- TABLE 163. Asia-Pacific Pharmaceutical Outsourcing Services Market Size, by Development Phase, 2017-2032 (USD Million)
- TABLE 164. Asia-Pacific Pharmaceutical Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
- TABLE 165. Asia-Pacific Pharmaceutical Outsourcing Services Market Size, by End User, 2017-2032 (USD Million)
- TABLE 166. Asia-Pacific Pharmaceutical Outsourcing Services Market Size, by Contract Model, 2017-2032 (USD Million)
- TABLE 167. Asia-Pacific Pharmaceutical Outsourcing Services Market Size, by Dedicated Project Team, 2017-2032 (USD Million)
- TABLE 168. Asia-Pacific Pharmaceutical Outsourcing Services Market Size, by Fixed Price, 2017-2032 (USD Million)
- TABLE 169. Asia-Pacific Pharmaceutical Outsourcing Services Market Size, by Risk-Sharing, 2017-2032 (USD Million)
- TABLE 170. Asia-Pacific Pharmaceutical Outsourcing Services Market Size, by Time & Material, 2017-2032 (USD Million)
- TABLE 171. North America Pharmaceutical Outsourcing Services Market Size, by Region, 2017-2032 (USD Million)
- TABLE 172. North America Pharmaceutical Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
- TABLE 173. North America Pharmaceutical Outsourcing Services Market Size, by Analytical Testing, 2017-2032 (USD Million)
- TABLE 174. North America Pharmaceutical Outsourcing Services Market Size, by Clinical Trial Management, 2017-2032 (USD Million)
- TABLE 175. North America Pharmaceutical Outsourcing Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
- TABLE 176. North America Pharmaceutical Outsourcing Services Market Size, by R&D Services, 2017-2032 (USD Million)
- TABLE 177. North America Pharmaceutical Outsourcing Services Market Size, by Regulatory Consulting, 2017-2032 (USD Million)
- TABLE 178. North America Pharmaceutical Outsourcing Services Market Size, by Development Phase, 2017-2032 (USD Million)
- TABLE 179. North America Pharmaceutical Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
- TABLE 180. North America Pharmaceutical Outsourcing Services Market Size, by End User, 2017-2032 (USD Million)
- TABLE 181. North America Pharmaceutical Outsourcing Services Market Size, by Contract Model, 2017-2032 (USD Million)
- TABLE 182. North America Pharmaceutical Outsourcing Services Market Size, by Dedicated Project Team, 2017-2032 (USD Million)
- TABLE 183. North America Pharmaceutical Outsourcing Services Market Size, by Fixed Price, 2017-2032 (USD Million)
- TABLE 184. North America Pharmaceutical Outsourcing Services Market Size, by Risk-Sharing, 2017-2032 (USD Million)
- TABLE 185. North America Pharmaceutical Outsourcing Services Market Size, by Time & Material, 2017-2032 (USD Million)
- TABLE 186. Latin America Pharmaceutical Outsourcing Services Market Size, by Region, 2017-2032 (USD Million)
- TABLE 187. Latin America Pharmaceutical Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
- TABLE 188. Latin America Pharmaceutical Outsourcing Services Market Size, by Analytical Testing, 2017-2032 (USD Million)
- TABLE 189. Latin America Pharmaceutical Outsourcing Services Market Size, by Clinical Trial Management, 2017-2032 (USD Million)
- TABLE 190. Latin America Pharmaceutical Outsourcing Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
- TABLE 191. Latin America Pharmaceutical Outsourcing Services Market Size, by R&D Services, 2017-2032 (USD Million)
- TABLE 192. Latin America Pharmaceutical Outsourcing Services Market Size, by Regulatory Consulting, 2017-2032 (USD Million)
- TABLE 193. Latin America Pharmaceutical Outsourcing Services Market Size, by Development Phase, 2017-2032 (USD Million)
- TABLE 194. Latin America Pharmaceutical Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
- TABLE 195. Latin America Pharmaceutical Outsourcing Services Market Size, by End User, 2017-2032 (USD Million)
- TABLE 196. Latin America Pharmaceutical Outsourcing Services Market Size, by Contract Model, 2017-2032 (USD Million)
- TABLE 197. Latin America Pharmaceutical Outsourcing Services Market Size, by Dedicated Project Team, 2017-2032 (USD Million)
- TABLE 198. Latin America Pharmaceutical Outsourcing Services Market Size, by Fixed Price, 2017-2032 (USD Million)
- TABLE 199. Latin America Pharmaceutical Outsourcing Services Market Size, by Risk-Sharing, 2017-2032 (USD Million)
- TABLE 200. Latin America Pharmaceutical Outsourcing Services Market Size, by Time & Material, 2017-2032 (USD Million)
- TABLE 201. Europe Pharmaceutical Outsourcing Services Market Size, by Region, 2017-2032 (USD Million)
- TABLE 202. Europe Pharmaceutical Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
- TABLE 203. Europe Pharmaceutical Outsourcing Services Market Size, by Analytical Testing, 2017-2032 (USD Million)
- TABLE 204. Europe Pharmaceutical Outsourcing Services Market Size, by Clinical Trial Management, 2017-2032 (USD Million)
- TABLE 205. Europe Pharmaceutical Outsourcing Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
- TABLE 206. Europe Pharmaceutical Outsourcing Services Market Size, by R&D Services, 2017-2032 (USD Million)
- TABLE 207. Europe Pharmaceutical Outsourcing Services Market Size, by Regulatory Consulting, 2017-2032 (USD Million)
- TABLE 208. Europe Pharmaceutical Outsourcing Services Market Size, by Development Phase, 2017-2032 (USD Million)
- TABLE 209. Europe Pharmaceutical Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
- TABLE 210. Europe Pharmaceutical Outsourcing Services Market Size, by End User, 2017-2032 (USD Million)
- TABLE 211. Europe Pharmaceutical Outsourcing Services Market Size, by Contract Model, 2017-2032 (USD Million)
- TABLE 212. Europe Pharmaceutical Outsourcing Services Market Size, by Dedicated Project Team, 2017-2032 (USD Million)
- TABLE 213. Europe Pharmaceutical Outsourcing Services Market Size, by Fixed Price, 2017-2032 (USD Million)
- TABLE 214. Europe Pharmaceutical Outsourcing Services Market Size, by Risk-Sharing, 2017-2032 (USD Million)
- TABLE 215. Europe Pharmaceutical Outsourcing Services Market Size, by Time & Material, 2017-2032 (USD Million)
- TABLE 216. Middle East Pharmaceutical Outsourcing Services Market Size, by Region, 2017-2032 (USD Million)
- TABLE 217. Middle East Pharmaceutical Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
- TABLE 218. Middle East Pharmaceutical Outsourcing Services Market Size, by Analytical Testing, 2017-2032 (USD Million)
- TABLE 219. Middle East Pharmaceutical Outsourcing Services Market Size, by Clinical Trial Management, 2017-2032 (USD Million)
- TABLE 220. Middle East Pharmaceutical Outsourcing Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
- TABLE 221. Middle East Pharmaceutical Outsourcing Services Market Size, by R&D Services, 2017-2032 (USD Million)
- TABLE 222. Middle East Pharmaceutical Outsourcing Services Market Size, by Regulatory Consulting, 2017-2032 (USD Million)
- TABLE 223. Middle East Pharmaceutical Outsourcing Services Market Size, by Development Phase, 2017-2032 (USD Million)
- TABLE 224. Middle East Pharmaceutical Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
- TABLE 225. Middle East Pharmaceutical Outsourcing Services Market Size, by End User, 2017-2032 (USD Million)
- TABLE 226. Middle East Pharmaceutical Outsourcing Services Market Size, by Contract Model, 2017-2032 (USD Million)
- TABLE 227. Middle East Pharmaceutical Outsourcing Services Market Size, by Dedicated Project Team, 2017-2032 (USD Million)
- TABLE 228. Middle East Pharmaceutical Outsourcing Services Market Size, by Fixed Price, 2017-2032 (USD Million)
- TABLE 229. Middle East Pharmaceutical Outsourcing Services Market Size, by Risk-Sharing, 2017-2032 (USD Million)
- TABLE 230. Middle East Pharmaceutical Outsourcing Services Market Size, by Time & Material, 2017-2032 (USD Million)
- TABLE 231. Africa Pharmaceutical Outsourcing Services Market Size, by Region, 2017-2032 (USD Million)
- TABLE 232. Africa Pharmaceutical Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
- TABLE 233. Africa Pharmaceutical Outsourcing Services Market Size, by Analytical Testing, 2017-2032 (USD Million)
- TABLE 234. Africa Pharmaceutical Outsourcing Services Market Size, by Clinical Trial Management, 2017-2032 (USD Million)
- TABLE 235. Africa Pharmaceutical Outsourcing Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
- TABLE 236. Africa Pharmaceutical Outsourcing Services Market Size, by R&D Services, 2017-2032 (USD Million)
- TABLE 237. Africa Pharmaceutical Outsourcing Services Market Size, by Regulatory Consulting, 2017-2032 (USD Million)
- TABLE 238. Africa Pharmaceutical Outsourcing Services Market Size, by Development Phase, 2017-2032 (USD Million)
- TABLE 239. Africa Pharmaceutical Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
- TABLE 240. Africa Pharmaceutical Outsourcing Services Market Size, by End User, 2017-2032 (USD Million)
- TABLE 241. Africa Pharmaceutical Outsourcing Services Market Size, by Contract Model, 2017-2032 (USD Million)
- TABLE 242. Africa Pharmaceutical Outsourcing Services Market Size, by Dedicated Project Team, 2017-2032 (USD Million)
- TABLE 243. Africa Pharmaceutical Outsourcing Services Market Size, by Fixed Price, 2017-2032 (USD Million)
- TABLE 244. Africa Pharmaceutical Outsourcing Services Market Size, by Risk-Sharing, 2017-2032 (USD Million)
- TABLE 245. Africa Pharmaceutical Outsourcing Services Market Size, by Time & Material, 2017-2032 (USD Million)
- TABLE 246. Global Pharmaceutical Outsourcing Services Market Size, by Group, 2017-2032 (USD Million)
- TABLE 247. ASEAN Pharmaceutical Outsourcing Services Market Size, by Group, 2017-2032 (USD Million)
- TABLE 248. ASEAN Pharmaceutical Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
- TABLE 249. ASEAN Pharmaceutical Outsourcing Services Market Size, by Analytical Testing, 2017-2032 (USD Million)
- TABLE 250. ASEAN Pharmaceutical Outsourcing Services Market Size, by Clinical Trial Management, 2017-2032 (USD Million)
- TABLE 251. ASEAN Pharmaceutical Outsourcing Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
- TABLE 252. ASEAN Pharmaceutical Outsourcing Services Market Size, by R&D Services, 2017-2032 (USD Million)
- TABLE 253. ASEAN Pharmaceutical Outsourcing Services Market Size, by Regulatory Consulting, 2017-2032 (USD Million)
- TABLE 254. ASEAN Pharmaceutical Outsourcing Services Market Size, by Development Phase, 2017-2032 (USD Million)
- TABLE 255. ASEAN Pharmaceutical Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
- TABLE 256. ASEAN Pharmaceutical Outsourcing Services Market Size, by End User, 2017-2032 (USD Million)
- TABLE 257. ASEAN Pharmaceutical Outsourcing Services Market Size, by Contract Model, 2017-2032 (USD Million)
- TABLE 258. ASEAN Pharmaceutical Outsourcing Services Market Size, by Dedicated Project Team, 2017-2032 (USD Million)
- TABLE 259. ASEAN Pharmaceutical Outsourcing Services Market Size, by Fixed Price, 2017-2032 (USD Million)
- TABLE 260. ASEAN Pharmaceutical Outsourcing Services Market Size, by Risk-Sharing, 2017-2032 (USD Million)
- TABLE 261. ASEAN Pharmaceutical Outsourcing Services Market Size, by Time & Material, 2017-2032 (USD Million)
- TABLE 262. GCC Pharmaceutical Outsourcing Services Market Size, by Group, 2017-2032 (USD Million)
- TABLE 263. GCC Pharmaceutical Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
- TABLE 264. GCC Pharmaceutical Outsourcing Services Market Size, by Analytical Testing, 2017-2032 (USD Million)
- TABLE 265. GCC Pharmaceutical Outsourcing Services Market Size, by Clinical Trial Management, 2017-2032 (USD Million)
- TABLE 266. GCC Pharmaceutical Outsourcing Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
- TABLE 267. GCC Pharmaceutical Outsourcing Services Market Size, by R&D Services, 2017-2032 (USD Million)
- TABLE 268. GCC Pharmaceutical Outsourcing Services Market Size, by Regulatory Consulting, 2017-2032 (USD Million)
- TABLE 269. GCC Pharmaceutical Outsourcing Services Market Size, by Development Phase, 2017-2032 (USD Million)
- TABLE 270. GCC Pharmaceutical Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
- TABLE 271. GCC Pharmaceutical Outsourcing Services Market Size, by End User, 2017-2032 (USD Million)
- TABLE 272. GCC Pharmaceutical Outsourcing Services Market Size, by Contract Model, 2017-2032 (USD Million)
- TABLE 273. GCC Pharmaceutical Outsourcing Services Market Size, by Dedicated Project Team, 2017-2032 (USD Million)
- TABLE 274. GCC Pharmaceutical Outsourcing Services Market Size, by Fixed Price, 2017-2032 (USD Million)
- TABLE 275. GCC Pharmaceutical Outsourcing Services Market Size, by Risk-Sharing, 2017-2032 (USD Million)
- TABLE 276. GCC Pharmaceutical Outsourcing Services Market Size, by Time & Material, 2017-2032 (USD Million)
- TABLE 277. European Union Pharmaceutical Outsourcing Services Market Size, by Group, 2017-2032 (USD Million)
- TABLE 278. European Union Pharmaceutical Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
- TABLE 279. European Union Pharmaceutical Outsourcing Services Market Size, by Analytical Testing, 2017-2032 (USD Million)
- TABLE 280. European Union Pharmaceutical Outsourcing Services Market Size, by Clinical Trial Management, 2017-2032 (USD Million)
- TABLE 281. European Union Pharmaceutical Outsourcing Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
- TABLE 282. European Union Pharmaceutical Outsourcing Services Market Size, by R&D Services, 2017-2032 (USD Million)
- TABLE 283. European Union Pharmaceutical Outsourcing Services Market Size, by Regulatory Consulting, 2017-2032 (USD Million)
- TABLE 284. European Union Pharmaceutical Outsourcing Services Market Size, by Development Phase, 2017-2032 (USD Million)
- TABLE 285. European Union Pharmaceutical Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
- TABLE 286. European Union Pharmaceutical Outsourcing Services Market Size, by End User, 2017-2032 (USD Million)
- TABLE 287. European Union Pharmaceutical Outsourcing Services Market Size, by Contract Model, 2017-2032 (USD Million)
- TABLE 288. European Union Pharmaceutical Outsourcing Services Market Size, by Dedicated Project Team, 2017-2032 (USD Million)
- TABLE 289. European Union Pharmaceutical Outsourcing Services Market Size, by Fixed Price, 2017-2032 (USD Million)
- TABLE 290. European Union Pharmaceutical Outsourcing Services Market Size, by Risk-Sharing, 2017-2032 (USD Million)
- TABLE 291. European Union Pharmaceutical Outsourcing Services Market Size, by Time & Material, 2017-2032 (USD Million)
- TABLE 292. BRICS Pharmaceutical Outsourcing Services Market Size, by Group, 2017-2032 (USD Million)
- TABLE 293. BRICS Pharmaceutical Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
- TABLE 294. BRICS Pharmaceutical Outsourcing Services Market Size, by Analytical Testing, 2017-2032 (USD Million)
- TABLE 295. BRICS Pharmaceutical Outsourcing Services Market Size, by Clinical Trial Management, 2017-2032 (USD Million)
- TABLE 296. BRICS Pharmaceutical Outsourcing Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
- TABLE 297. BRICS Pharmaceutical Outsourcing Services Market Size, by R&D Services, 2017-2032 (USD Million)
- TABLE 298. BRICS Pharmaceutical Outsourcing Services Market Size, by Regulatory Consulting, 2017-2032 (USD Million)
- TABLE 299. BRICS Pharmaceutical Outsourcing Services Market Size, by Development Phase, 2017-2032 (USD Million)
- TABLE 300. BRICS Pharmaceutical Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
- TABLE 301. BRICS Pharmaceutical Outsourcing Services Market Size, by End User, 2017-2032 (USD Million)
- TABLE 302. BRICS Pharmaceutical Outsourcing Services Market Size, by Contract Model, 2017-2032 (USD Million)
- TABLE 303. BRICS Pharmaceutical Outsourcing Services Market Size, by Dedicated Project Team, 2017-2032 (USD Million)
- TABLE 304. BRICS Pharmaceutical Outsourcing Services Market Size, by Fixed Price, 2017-2032 (USD Million)
- TABLE 305. BRICS Pharmaceutical Outsourcing Services Market Size, by Risk-Sharing, 2017-2032 (USD Million)
- TABLE 306. BRICS Pharmaceutical Outsourcing Services Market Size, by Time & Material, 2017-2032 (USD Million)
- TABLE 307. G7 Pharmaceutical Outsourcing Services Market Size, by Group, 2017-2032 (USD Million)
- TABLE 308. G7 Pharmaceutical Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
- TABLE 309. G7 Pharmaceutical Outsourcing Services Market Size, by Analytical Testing, 2017-2032 (USD Million)
- TABLE 310. G7 Pharmaceutical Outsourcing Services Market Size, by Clinical Trial Management, 2017-2032 (USD Million)
- TABLE 311. G7 Pharmaceutical Outsourcing Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
- TABLE 312. G7 Pharmaceutical Outsourcing Services Market Size, by R&D Services, 2017-2032 (USD Million)
- TABLE 313. G7 Pharmaceutical Outsourcing Services Market Size, by Regulatory Consulting, 2017-2032 (USD Million)
- TABLE 314. G7 Pharmaceutical Outsourcing Services Market Size, by Development Phase, 2017-2032 (USD Million)
- TABLE 315. G7 Pharmaceutical Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
- TABLE 316. G7 Pharmaceutical Outsourcing Services Market Size, by End User, 2017-2032 (USD Million)
- TABLE 317. G7 Pharmaceutical Outsourcing Services Market Size, by Contract Model, 2017-2032 (USD Million)
- TABLE 318. G7 Pharmaceutical Outsourcing Services Market Size, by Dedicated Project Team, 2017-2032 (USD Million)
- TABLE 319. G7 Pharmaceutical Outsourcing Services Market Size, by Fixed Price, 2017-2032 (USD Million)
- TABLE 320. G7 Pharmaceutical Outsourcing Services Market Size, by Risk-Sharing, 2017-2032 (USD Million)
- TABLE 321. G7 Pharmaceutical Outsourcing Services Market Size, by Time & Material, 2017-2032 (USD Million)
- TABLE 322. NATO Pharmaceutical Outsourcing Services Market Size, by Group, 2017-2032 (USD Million)
- TABLE 323. NATO Pharmaceutical Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
- TABLE 324. NATO Pharmaceutical Outsourcing Services Market Size, by Analytical Testing, 2017-2032 (USD Million)
- TABLE 325. NATO Pharmaceutical Outsourcing Services Market Size, by Clinical Trial Management, 2017-2032 (USD Million)
- TABLE 326. NATO Pharmaceutical Outsourcing Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
- TABLE 327. NATO Pharmaceutical Outsourcing Services Market Size, by R&D Services, 2017-2032 (USD Million)
- TABLE 328. NATO Pharmaceutical Outsourcing Services Market Size, by Regulatory Consulting, 2017-2032 (USD Million)
TABLE 329
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.